Protective effects of spironolactone on vascular calcification in chronic kidney disease.
Hammer F, Buehling SS, Masyout J, Malzahn U, Hauser T, Auer T, Grebe S, Feger M, Tuffaha R, Degenhart G, Lang F, Pasch A, Alesutan I, Wanner C, Krane V, Voelkl J.
Hammer F, et al. Among authors: feger m.
Biochem Biophys Res Commun. 2021 Dec 10;582:28-34. doi: 10.1016/j.bbrc.2021.10.023. Epub 2021 Oct 10.
Biochem Biophys Res Commun. 2021.
PMID: 34678593
Free article.
Clinical Trial.